Alon Gurfinkel
Lawyers
Filters
Biodesix $50 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Forbion European Acquisition $126.5 million IPO
We advised Forbion European Acquisition, a SPAC, on its IPO and Nasdaq listing
Net Protections ¥67.7 billion IPO
The shares are listed on the Tokyo Stock Exchange
Perion Network $180 million follow-on offering
We advised Perion on the offering of ordinary shares
Target Global Acquisition I $200 million IPO
We advised Target Global Acquisition I, a SPAC, on its IPO and Nasdaq listing
CANbridge Pharmaceuticals HK$685 million IPO
We advised CANbridge Pharmaceuticals on its IPO and HKEX listing
Olympus $500 million senior notes offering
The debut offering consisted of 2.143% senior notes due 2026
Alm. Brand DKK 10.47 billion rights offering
The offering included 1,387,026,000 shares
NXP $2 billion senior notes offering
The investment-grade notes are due 2032, 2042 and 2051
Bilibili $1.6 billion sustainable convertible notes offering
The 0.5% convertible senior notes are due 2026